One-year results of Royal Philips' DEFINE PCI study -- which is investigating Philips' blinded instant wave-free ratio pullback measurement guidance technology for percutaneous coronary intervention -- show less recurrent angina and improved outcomes. "The one-year data from DEFINE PCI are the latest evidence that iFR contributes to reduced costs, enhanced patient experience and improved outcomes for PCI procedures [2, 3, 4]," said Chris Landon, Philips' senior vice president and general manager of image-guided therapy devices.
Philips' post-stent imaging study shows positive results
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.